Sterile Medical Packaging Market Share

North America Market Insights

North America sterile medical packaging market is forecasted to emerge with the largest revenue share of 38.6% during the discussed timeframe. Advanced healthcare systems, strong regulatory frameworks, and high adoption of sterile-packaged medical devices mainly propel the region’s dominance in this field. In July 2025, Mubadala Investment Company reported that it made a significant reinvestment in PCI Pharma Services, which is a global CDMO specializing in biotherapies, to support both organic and inorganic growth initiatives. The funding will expand PCI’s sterile fill-finish capabilities, high-potency, and specialized manufacturing capacity, particularly in the US, strengthening critical pharmaceutical supply chains. Hence, this strategic move underscores the growing demand for advanced sterile manufacturing solutions, positively influenced by biologics and specialized drug therapies.

The U.S. sterile medical packaging market is growing exponentially on account of increasing healthcare expenditure and increased demand for single-use devices. The country’s growth is also fueled by the extensive need for materials such as plastics, paper, and foils for medical devices, pharmaceuticals, and surgical supplies.  For instance, in February 2023, West Pharmaceutical Services, Inc. announced that it had launched West Ready Pack with Corning Valor RTU vials, which is a sterile, ready-to-use containment solution for injectable drugs and diagnostics. The company also notes that this product integrates sterilized elastomer components and glass vials into a single-use packaging system, thereby addressing growing healthcare demand for contamination-free, ready-to-fill solutions. Hence, such instances reflect increasing U.S. healthcare expenditure and the rising need for sterile packaging materials for pharmaceuticals and medical devices.

Canada sterile medical packaging market has gained increased exposure owing to the heightened demand for infection prevention and advancements in terms of sustainable, recyclable materials and specialized barrier technologies. The country’s market is also driven by the increasing prevalence of chronic diseases and the need for sterile packaging to maintain the integrity of medical implants, instruments, and consumables. In July 2025, Winpak Ltd. announced that its Winnipeg, Manitoba, Canada site is now an authorized converter of DuPont Tyvek healthcare packaging, expanding its ability to produce sterile barrier packaging for medical devices and pharmaceuticals in Canada and North America. Winpak combines its MedForm DT films with Tyvekto deliver high-performance, contamination-resistant packaging that maintains sterility throughout the product lifecycle under the Wiicare brand.

APAC Market Insights

The Asia Pacific sterile medical packaging market is expected to register the fastest growth over the discussed timeframe. Manufacturers and service providers are focused on expanding local capabilities and technologies to serve the growing needs of pharmaceutical and medical device companies. In this context, Nelipak Healthcare Packaging in April 2025 announced an expansion of its direct services and partner network in the Asia Pacific, thereby enhancing access to its custom sterile barrier medical packaging solutions. The company’s offerings include flexible pouches, bags, coated papers and films, rigid thermoformed trays, and tray sealing machines, which are tailored to meet the unique technical requirements of healthcare companies in the region. Hence, the company is strengthening regional expertise, resources, and innovative packaging technologies, aiming to streamline processes and deliver value while supporting evolving customer needs.

China sterile medical packaging market maintains a central position in the regional landscape, primarily fueled by the expansion of pharmaceutical manufacturing and regulatory emphasis on quality and compliance. This, in turn, is prompting both national and international players to adopt high-barrier materials and automation in sterile packaging production to meet both local healthcare demand and export-oriented standards. In this context, in September 2024, Nais Medical Packaging Technology (Shenzhen) Co., Ltd. stated that it participated in the 90th China International Medical Devices Expo by showcasing its aseptic packaging solutions for medical devices. Besides, the company emphasizes innovation in sterile medical packaging and serves both domestic and international Class II and III medical device manufacturers with high-quality solutions. In addition, by engaging in such major exhibitions, Nais represents a strong focus on advancing sterile packaging technologies and strengthening connections within the country’s medical device supply chain.

India sterile medical packaging market is showcasing notable progress owing to the rising production of injectable pharmaceuticals and biosimilars. This, in turn, is encouraging the packaging equipment and solutions providers to support aseptic processing and traceability in both medical device and pharmaceutical packaging.  In August 2025, SCHOTT Glass India reported that it became the first company in India to locally produce high-precision syringe and cartridge glass tubing at its Gujarat facility, supporting the growing demand for GLP-1-based injectables such as semaglutide. Also, this expansion strengthens the country’s sterile pharmaceutical packaging supply chain, enabling consistent, high-quality production for prefillable syringes and cartridges at the same time advancing aseptic processing capabilities. It is aligned with the Make in India initiative, whereas SCHOTT’s investment reinforces local pharmaceutical self-reliance.

Europe Market Insights

Europe sterile medical packaging market is reshaped by stringent regulations such as the EU Medical Device Regulation (MDR), and sustainable packaging mandates wherein the manufacturers are incorporating eco-friendly materials and designs to comply. The presence of leading market pioneers and their strategic steps also fosters a favorable business ecosystem in the region. In June 2023, Oliver Healthcare Packaging announced that it had acquired EK-Pack Folien GmbH in Germany, which is a prominent manufacturer of high-quality film and foil laminations for sterile barrier packaging. The company also notes that this acquisition adds 23,000 square meters of manufacturing space with 8 production lines, thereby allowing it to insource materials and innovate new healthcare packaging products. This move further complements Oliver’s recent investments in the region, including expanding its Venray, Netherlands facility and adding automation and converting equipment to enhance regional support in the upcoming years.

Germany sterile medical packaging market is growing significantly due to a strong pharmaceutical and medical device manufacturing base. The country’s precision packaging and compliance with high regulatory standards drive local providers to innovate continuously in terms of sterile barrier systems and support integration with automated production lines.  In this context, Recipharm in February 2025, Recipharm notified the launch of a modular sterile filling system at its Wasserburg, Germany, facility, which is especially designed for process development, pilot scale, and clinical supply projects under GMP-compliant Grade A isolator conditions. This system supports various containers such as syringes and vials, and optimizes small-batch production, making it suitable for advanced therapies and rare disease pharmaceuticals. Hence, this addition complements Recipharm’s existing sterile development and commercial capabilities, significantly enhancing flexibility and efficiency for both biotech and pharmaceutical clients.

Germany Sterile Medical Device Sub-Sectors Driving Packaging Demand  (2024-2030)

Source: ITA

The UK sterile medical packaging market is also developing due to the increasing adoption of single-use medical devices and the heightened demand for injectable pharmaceuticals. Rising healthcare infrastructure development and stringent regulatory standards for aseptic packaging are driving manufacturers to invest in advanced sterilization and barrier technologies. For instance, Sterimed in June 2024 finalized the acquisition of Riverside Medical Packaging, which is a leading provider of sterilization packaging systems and contract packing services in the country for the medical device industry. Riverside leverages 12 cleanrooms and specialized thermoforming capabilities and is recognized for its aseptic solutions. This acquisition strengthens Sterimed’s operations in the UK and expands its service offerings for medical device manufacturers, accelerating progress into pharmaceutical packaging applications.